Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Non-cash Items (2022 - 2024)

Quantum Biopharma's Non-cash Items history spans 3 years, with the latest figure at $2.7 million for Q2 2024.

  • On a quarterly basis, Non-cash Items changed N/A to $2.7 million in Q2 2024 year-over-year; TTM through Jun 2024 was $2.7 million, a N/A change, with the full-year FY2023 number at $2.5 million, up 487.92% from a year prior.
  • Non-cash Items hit $2.7 million in Q2 2024 for Quantum Biopharma, up from $2.6 million in the prior quarter.
  • Over the last five years, Non-cash Items for QNTM hit a ceiling of $2.7 million in Q1 2023 and a floor of $418529.0 in Q4 2022.
  • Historically, Non-cash Items has averaged $2.2 million across 3 years, with a median of $2.6 million in 2024.
  • Biggest five-year swings in Non-cash Items: skyrocketed 487.92% in 2023 and later dropped 2.83% in 2024.
  • Tracing QNTM's Non-cash Items over 3 years: stood at $418529.0 in 2022, then skyrocketed by 487.92% to $2.5 million in 2023, then rose by 8.37% to $2.7 million in 2024.
  • Business Quant data shows Non-cash Items for QNTM at $2.7 million in Q2 2024, $2.6 million in Q1 2024, and $2.5 million in Q4 2023.